strategy to combat antimicrobial resistance is the identification of novel therapeutic targets and anti-infectives with alternative mechanisms of action. The inhibition of the metalloenzymes carbonic anhydrases (CAs, EC 4.2.1.1) from pathogens (bacteria, fungi, and protozoa) was shown to produce an impairment of the microorganism growth and virulence. As phosphonamidates have been recently validated
对抗抗菌素耐药性的主要策略是鉴定具有替代作用机制的新型治疗靶标和抗感染药。结果表明,抑制病原体(细菌,真菌和原生动物)的
金属酶
碳酸酐酶(CAs,
EC 4.2.1.1)会损害微
生物的生长和毒性。由于最近已验证了
氨基
磷酸膦酸酯是人的α-CA
抑制剂(CAIs),并且迄今为止尚未评估基于
磷的
锌结合基团对β-类CA的抑制作用,本文中我们报道了这类化合物对β-CA的抑制作用研究来自病原细菌,真菌和原生动物。我们的数据表明,膦酰胺盐是对人类同工酶对β-类具有最佳选择性的CAI之一,这使它们成为开发新型抗感染药的有趣线索。